BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12806133)

  • 1. Calcitonin gene-related peptide in tension-type headache.
    Ashina M
    ScientificWorldJournal; 2002 Jun; 2():1527-31. PubMed ID: 12806133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of calcitonin gene-related peptide in chronic tension-type headache.
    Ashina M; Bendtsen L; Jensen R; Schifter S; Jansen-Olesen I; Olesen J
    Neurology; 2000 Nov; 55(9):1335-40. PubMed ID: 11087777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcitonin gene-related peptide (CGRP) and the pathophysiology of headache: therapeutic implications.
    Edvinsson L
    CNS Drugs; 2001; 15(10):745-53. PubMed ID: 11602001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma calcitonin gene-related peptide concentration is comparable to control group among migraineurs and tension type headache subjects during inter-ictal period.
    Gupta R; Ahmed T; Banerjee B; Bhatia M
    J Headache Pain; 2009 Jun; 10(3):161-6. PubMed ID: 19277835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcitonin gene-related peptide levels during nitric oxide-induced headache in patients with chronic tension-type headache.
    Ashina M; Bendtsen L; Jensen R; Schifter S; Olesen J
    Eur J Neurol; 2001 Mar; 8(2):173-8. PubMed ID: 11284996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central sensitization in tension-type headache--possible pathophysiological mechanisms.
    Bendtsen L
    Cephalalgia; 2000 Jun; 20(5):486-508. PubMed ID: 11037746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CGRP in human models of primary headaches.
    Ashina H; Schytz HW; Ashina M
    Cephalalgia; 2018 Feb; 38(2):353-360. PubMed ID: 27940880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution.
    Lennerz JK; Rühle V; Ceppa EP; Neuhuber WL; Bunnett NW; Grady EF; Messlinger K
    J Comp Neurol; 2008 Mar; 507(3):1277-99. PubMed ID: 18186028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcitonin gene-related peptide antagonism and cluster headache: an emerging new treatment.
    Ashina H; Newman L; Ashina S
    Neurol Sci; 2017 Dec; 38(12):2089-2093. PubMed ID: 28856479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcitonin gene-related peptide in cervicogenic headache.
    Frese A; Schilgen M; Edvinsson L; Frandsen E; Evers S
    Cephalalgia; 2005 Sep; 25(9):700-3. PubMed ID: 16109051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcitonin gene-related peptide (CGRP) in cerebrovascular disease.
    Edvinsson L
    ScientificWorldJournal; 2002 May; 2():1484-90. PubMed ID: 12805934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitonin gene-related peptide enhances release of native brain-derived neurotrophic factor from trigeminal ganglion neurons.
    Buldyrev I; Tanner NM; Hsieh HY; Dodd EG; Nguyen LT; Balkowiec A
    J Neurochem; 2006 Dec; 99(5):1338-50. PubMed ID: 17064360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of nerve fibers storing CGRP and CGRP receptors in the peripheral trigeminovascular system.
    Eftekhari S; Warfvinge K; Blixt FW; Edvinsson L
    J Pain; 2013 Nov; 14(11):1289-303. PubMed ID: 23958278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcitonin gene-related peptide (CGRP) levels during glyceryl trinitrate (GTN)-induced headache in healthy volunteers.
    Kruuse C; Iversen HK; Jansen-Olesen I; Edvinsson L; Olesen J
    Cephalalgia; 2010 Apr; 30(4):467-74. PubMed ID: 19673898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensory nerve fibers containing calcitonin gene-related peptide in gastrocnemius, latissimus dorsi and erector spinae muscles and thoracolumbar fascia in mice.
    Barry CM; Kestell G; Gillan M; Haberberger RV; Gibbins IL
    Neuroscience; 2015 Apr; 291():106-17. PubMed ID: 25681518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihyperalgesic effect of a recombinant herpes virus encoding antisense for calcitonin gene-related peptide.
    Tzabazis AZ; Pirc G; Votta-Velis E; Wilson SP; Laurito CE; Yeomans DC
    Anesthesiology; 2007 Jun; 106(6):1196-203. PubMed ID: 17525595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology of tension-type headache.
    Ashina S; Bendtsen L; Ashina M
    Curr Pain Headache Rep; 2005 Dec; 9(6):415-22. PubMed ID: 16282042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CGRP and NO in the trigeminal system: mechanisms and role in headache generation.
    Messlinger K; Lennerz JK; Eberhardt M; Fischer MJ
    Headache; 2012 Oct; 52(9):1411-27. PubMed ID: 22788114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of CGRP receptors in the intracranial vasculature: a new target in the treatment of headache.
    Edvinsson L
    Cephalalgia; 2004 Aug; 24(8):611-22. PubMed ID: 15265049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of rat cranial dura mater with potassium chloride causes CGRP release into the cerebrospinal fluid and increases medullary blood flow.
    Dux M; Will C; Eberhardt M; Fischer MJM; Messlinger K
    Neuropeptides; 2017 Aug; 64():61-68. PubMed ID: 28202186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.